Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have made a breakthrough in cancer ...

ToolGen, Inc. (KOSDAQ 199800), led by CEO Jong Sang Ryu and recognized as a global leader in genome editing technology, announced today that it has filed a patent infringement lawsuit in the United ...

Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD's Innovative Dual-Targeting CAR-T Therapy, 'P134 Cell Injection,' which has received Investigational New Drug (IND) ...

Discover the rewilding trend and learn simple ways to reconnect with nature daily—no matter where you live, even in the city.

Researchers have developed a method to extract living cells from feces that they say could help conservationists better ...

Gilead Sciences has made another foray into the natural killer (NK) cell category, paying $300 million upfront to access Dragonfly Therapeutics' TriNKET platform to find therapies for cancer and ...

Gilead Sciences' cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off ...

mast cells, monocytes and macrophages, neutrophils and NK cells. We identify an age-related subpopulation of RETNLγ + LCN2 + senescence-like neutrophils (RLSNs) that preferentially accumulate in ...

Why bats can harbor viruses like hantavirus and coronavirus—pathogens that are highly dangerous to humans—without becoming ...

Scientists have discovered a new immunotherapy strategy that reduces cancer recurrence in mouse experimental models. The study, published in Nature Communications, shows that a specific subtype of ...

Pilly Labs Sets the Gold Standard in Functional Mushroom Gummies with Potent Fruiting Body Extracts for Energy, Focus, and ...